1887

Journal of General Virology header logo

Volume 83, Issue 4

Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species Free

Abstract

Of the known neutralizing antigenic sites of foot-and-mouth disease virus (FMDV), site 1 or A, formed in part by the G–H loop of VP1, has historically been considered immunodominant because of evidence implicating its importance in the induction of a protective immune response. However, no systematic study has been done to determine the relative importance of the various specificities of antibodies against the known neutralizing antigenic sites of FMDV in the polyclonal immune response of a natural host after vaccination. In this report, we have adopted a monoclonal antibody-based competition ELISA and used antibodies specific to sites 1, 2 and 3 to provide some insight into this issue. Following vaccination of the three main target species, cattle, pigs and sheep, with an O serotype strain, results indicate that none of these three antigenic sites can be considered immunodominant in a polyclonal serum. Interestingly, pigs did not respond to epitopes on the carboxy terminus end of VP1 as efficiently as the ruminant species. In addition to the known sites, other as yet undefined sites might also be important in the induction of a protective immune response. Possible implications for the design of new vaccine strategies for foot-and-mouth disease are discussed.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-4-775
2002-04-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/4/0830775a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-4-775&mimeType=html&fmt=ahah

References

  1. Aktas S., Samuel A. R. 2000; Identification of antigenic epitopes on the foot and mouth disease virus isolate O1/Manisa/Turkey/69 using monoclonal antibodies. Revue Scientifique et Technique Office International des Epizooties 19:744–753
     [Google Scholar]
  2. Bachrach H. L., Moore D. M., McKercher P. D., Polatnick J. 1975; Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. Journal of Immunology 115:1636–1641
     [Google Scholar]
  3. Barnett P. V., Samuel A. R., Pullen L., Ansell D., Butcher R. N., Parkhouse R. M. E. 1998; Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse. Journal of General Virology 79:1687–1697
     [Google Scholar]
  4. Barnett P. V., Ouldridge E. J., Rowlands D. J., Brown F., Parry N. R. 1989; Neutralization epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. Journal of General Virology 70:1483–1491
     [Google Scholar]
  5. Baxt B., Vakharia V., Moore D. M., Franke A. J., Morgan D. O. 1989; Analysis of neutralising antigenic sites on the surface of type A12 foot-and-mouth disease virus. Journal of Virology 63:2143–2151
     [Google Scholar]
  6. Bittle J. L., Houghten R. A., Alexander H., Shinnick T. M., Sutcliffe J. G., Lerner R. A., Rowlands D. J., Brown F. 1982; Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298:30–33
     [Google Scholar]
  7. Brocchi E., Civardi A., De Dimone F., Panina G. F. 1983; Characterisation of foot-and-mouth disease virus antibodies. 20th Congress of the Italian Society of Microbiology, Gardone, Italy. Atti della Societa Italiana delle Scienze Veterinarie 36:576–578
     [Google Scholar]
  8. Brown F., Cartwright B. 1963; Purification of radioactive foot-and-mouth disease virus. Nature 199:1168–1170
     [Google Scholar]
  9. Brown A. L., Francis M. J., Hastings G. Z., Parry N. R., Barnett P. V., Rowlands D. J., Clarke B. E. 1991; Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted. Vaccine 9:595–601
     [Google Scholar]
  10. Crowther J. R., Farias S., Carpenter W. C., Samuel A. R. 1993; Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. Journal of General Virology 74:1547–1553
     [Google Scholar]
  11. DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T., Mowat N. 1986; Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232:639–641
     [Google Scholar]
  12. Dunn C. S., Samuel A. R., Pullen L. A., Anderson J. 1998; The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease. Virology 247:51–61
     [Google Scholar]
  13. Feigelstock D., Mateu M. G., Piccone M. E., De Simone F., Brocchi E., Domingo E., Palma E. L. 1992; Extensive antigenic diversification of foot-and-mouth disease virus by amino acid substitutions outside the major antigenic site. Journal of General Virology 73:3307–3311
     [Google Scholar]
  14. Garmendia A. E., Borca M. V., Morgan D. O., Baxt B. 1989; Analysis of foot-and-mouth disease virus-neutralizing idiotypes from immune bovine and swine with anti-murine idiotype antibody probes. Journal of Immunology 143:3015–3019
     [Google Scholar]
  15. Golding S. M., Hedger R. S., Talbot P. 1976; Radial immuno-diffusion and serum neutralisation techniques for the assay of antibodies to swine vesicular disease. Research in Veterinary Science 20:142–147
     [Google Scholar]
  16. Kitching R. P., Rendle R., Ferris N. P. 1988; Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus. Vaccine 6:403–408
     [Google Scholar]
  17. Kitson J. D. A., McCahon D., Belsham G. J. 1990; Sequence analysis of monoclonal antibody resistant mutants of type O foot-and-mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 179:26–34
     [Google Scholar]
  18. Kleid D. G., Yansura D., Small B., Dowbenko D., Moore D. M., Grubman M. J., Morgan D. O., Robertson B. H., Bachrach H. L. 1981; Cloned viral protein vaccine for foot-and-mouth disease. Responses in cattle and swine. Science 214:1125–1129
     [Google Scholar]
  19. McCullough K. C., Crowther J. R., Carpenter W. C., Brocchi E., Capucci L., De Simone F., Xie Q., McCahon D. 1987; Epitopes on foot-and-mouth disease virus particles. I. Topology. Virology 157:516–525
     [Google Scholar]
  20. Mason P. W., Piccone M. E., McKenna T. S. C., Chinsangaram J., Grubman M. J. 1997; Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 227:96–102
     [Google Scholar]
  21. Mateu M. G. 1995; Antibody recognition of picornaviruses and escape from neutralisation: a structural view. Virus Research 38:1–24
     [Google Scholar]
  22. Mateu M. G., Martínez M. A., Capucci L., Andreu D., Giralt E., Sobrino F., Brocchi E., Domingo E. 1990; A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. Journal of General Virology 71:629–637
     [Google Scholar]
  23. Mateu M. G., Camarero J. A., Giralt E., Andreu D., Domingo E. 1995; Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 206:298–306
     [Google Scholar]
  24. Mayr G. A., Chinsangaram J., Grubman M. J. 1999; Development of replication-defective Adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology 263:496–506
     [Google Scholar]
  25. Morgan D. O., Moore D. M. 1990; Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines. American Journal of Veterinary Research 51:40–45
     [Google Scholar]
  26. Pay T. W. F., Hingley P. J. 1987; Correlation of 140S antigen dose with the serum neutralising antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines. Vaccine 5:60–64
     [Google Scholar]
  27. Pfaff E., Mussgay M., Bohm H. O., Schulze G. E., Schaller H. 1982; Antibodies against a preselected peptide recognize and neutralize foot-and-mouth disease virus. EMBO Journal 1:869–874
     [Google Scholar]
  28. Samuel A. R. 1997; Genetic and antigenic studies on foot-and-mouth disease virus type O. PhD thesis University of Hertfordshire; UK:
  29. Sanz-Parra A., Jiménez-Clavero M. A., Garca-Briones M. M., Blanco E., Sobrino F., Ley V. 1999; Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology 259:129–134
     [Google Scholar]
  30. Sobrino F., Sáiz M., Jiménez-Clavero M. A., Núñez J. I., Rosas M. F., Baranowski E., Ley V. 2001; Foot-and-mouth disease virus: a long known virus, but a current threat. Veterinary Research 32:1–30
     [Google Scholar]
  31. Strohmaier K., Franze R., Adam K. H. 1982; Location and characterization of the antigenic portion of the FMDV immunizing protein. Journal of General Virology 59:295–306
     [Google Scholar]
  32. Taboga O., Tami C., Carrillo E., Núñez J. I., Rodríguez A., Sáiz J. C., Blanco E., Valero M., Roig X., Camarero J. A., Andreu D., Mateu M. G., Giralt E., Domingo E., Sobrino F., Palma E. L. 1997; A large-scale evaluation of peptide vaccines against foot-and-mouth disease: Lack of solid protection in cattle and isolation of escape mutants. Journal of Virology 71:2606–2614
     [Google Scholar]
  33. Thomas A. A. M., Woortmeijer R. J., Puijk W., Barteling S. J. 1988a; Antigenic sites on foot-and-mouth disease virus type A10. Journal of Virology 62:2782–2789
     [Google Scholar]
  34. Thomas A. A. M., Woortmeijer R. J., Barteling S. J., Meloen R. H. 1988b; Evidence for more than one important, neutralizing site on foot-and-mouth disease virus. Archives of Virology 99:237–242
     [Google Scholar]
  35. Ward G., Rieder E., Mason P. W. 1997; Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine. Journal of Virology 71:7442–7447
     [Google Scholar]
  36. Wild T. F., Burroughs J. N., Brown F. 1969; Surface structure of foot-and-mouth disease virus. Journal of General Virology 4:313–320
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-4-775
Loading
Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species
J. Gen. Virol. 83, 775 (2002); https://doi.org/10.1099/0022-1317-83-4-775
/content/journal/jgv/10.1099/0022-1317-83-4-775
/content/journal/jgv/10.1099/0022-1317-83-4-775
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error